May 13, 2020
Christopher Brown of Aristides Capital joins the podcast to
discuss his investment strategy, which has produced positive
returns every calendar year since 2008.
In Brown's view, healthcare and information technology stocks
should not be treated as defensive investments that will protect
portfolios in times of stress -- especially after their recent
run-up. There are reasons many companies in this sector are
overvalued and could see their shares drop as the economy begins to
see further difficulties from coronavirus.
Aristides Capital has an active short book, which framed most of
the second half of the conversation.
(Spotify users can link to the segment directly by clicking on the
- Why investors' thinking about defensive stocks may be misguided
- Growth stocks' recent performance is reminiscent of the
late-1990s tech bubble (7:05)
- The concerns with healthcare stocks (11:45)
- Background on the guest (15:07)
- Some of the red flags short sellers look for and why the "big
picture" is often more pertinent (20:22)
- Inovio Pharmaceuticals (NASDAQ: INO) discussion (22:52)
- CytoDyn Inc. (OTC: CYDY) discussion (25:44)
- Vuzix Corp. (NASDAQ: VUZI) discussion (28:37)
- Accelerate Diagnostics (NASDAQ: AXDX) discussion (30:59)
- Insider purchases are not always a bullish indicator
- Tesla Inc. (NASDAQ: TSLA) discussion, at the guest's suggestion
(host didn't want to go there originally) and why it could be an
indicator for future market direction (36:17)
- Reasons to be bearish on markets and the economy (39:17)
- How to protect your portfolio against inflation (42:13)
For more information on the guest:
Not intended as investment advice.